Sangfelt P - Search Results

1

Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease.

Wagner M, Peterson CG, Ridefelt P, Sangfelt P, Carlson M. Wagner M, et al. Among authors: sangfelt p. World J Gastroenterol. 2008 Sep 28;14(36):5584-9; discussion 5588. doi: 10.3748/wjg.14.5584. World J Gastroenterol. 2008. PMID: 18810778 Free PMC article.

2

Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis.

Sangfelt P, Carlson M, Thörn M, Lööf L, Raab Y. Sangfelt P, et al. Am J Gastroenterol. 2001 Apr;96(4):1085-90. doi: 10.1111/j.1572-0241.2001.03743.x. Am J Gastroenterol. 2001. PMID: 11316151

3

IL-5 and TNF-alpha participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis.

Lampinen M, Carlson M, Sangfelt P, Taha Y, Thörn M, Lööf L, Raab Y, Venge P. Lampinen M, et al. Among authors: sangfelt p. Dig Dis Sci. 2001 Sep;46(9):2004-9. doi: 10.1023/a:1010659803912. Dig Dis Sci. 2001. PMID: 11575456

4

Local release of human neutrophil lipocalin (HNL), IL-8, and TNF-alpha is decreased as response to topical prednisolone treatment in distal ulcerative colitis and proctitis.

Sangfelt P, Carlson M, Thörn M, Xu S, Lööf L, Raab Y. Sangfelt P, et al. Dig Dis Sci. 2002 Sep;47(9):2064-9. doi: 10.1023/a:1019681030784. Dig Dis Sci. 2002. PMID: 12353856

5

Serum ALT levels as a surrogate marker for serum HBV DNA levels in HBeAg-negative pregnant women.

Sangfelt P, Von Sydow M, Uhnoo I, Weiland O, Lindh G, Fischler B, Lindgren S, Reichard O. Sangfelt P, et al. Scand J Infect Dis. 2004;36(3):182-5. doi: 10.1080/00365540410027111. Scand J Infect Dis. 2004. PMID: 15119362

6

Eosinophil granulocytes are activated during the remission phase of ulcerative colitis.

Lampinen M, Rönnblom A, Amin K, Kristjansson G, Rorsman F, Sangfelt P, Säfsten B, Wagner M, Wanders A, Winqvist O, Carlson M. Lampinen M, et al. Among authors: sangfelt p. Gut. 2005 Dec;54(12):1714-20. doi: 10.1136/gut.2005.066423. Epub 2005 May 10. Gut. 2005. PMID: 15886302 Free PMC article.

7

The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids.

Egesten A, Eliasson M, Olin AI, Erjefält JS, Bjartell A, Sangfelt P, Carlson M. Egesten A, et al. Among authors: sangfelt p. Int J Colorectal Dis. 2007 Dec;22(12):1421-7. doi: 10.1007/s00384-007-0370-3. Epub 2007 Aug 17. Int J Colorectal Dis. 2007. PMID: 17703315 Clinical Trial.

8

Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis.

Peterson CG, Sangfelt P, Wagner M, Hansson T, Lettesjö H, Carlson M. Peterson CG, et al. Among authors: sangfelt p. Scand J Clin Lab Invest. 2007;67(8):810-20. doi: 10.1080/00365510701452838. Scand J Clin Lab Invest. 2007. PMID: 18034391

9

A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting.

Sangfelt P, Uhnoo I, Reichard O, Weiland O. Sangfelt P, et al. Scand J Gastroenterol. 2008;43(4):465-72. doi: 10.1080/00365520701733806. Scand J Gastroenterol. 2008. PMID: 18365912

10

Accumulation, activation, and survival of neutrophils in ulcerative colitis: regulation by locally produced factors in the colon and impact of steroid treatment.

Lampinen M, Sangfelt P, Taha Y, Carlson M. Lampinen M, et al. Among authors: sangfelt p. Int J Colorectal Dis. 2008 Oct;23(10):939-46. doi: 10.1007/s00384-008-0509-x. Epub 2008 Jul 2. Int J Colorectal Dis. 2008. PMID: 18594843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results